| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/22/2006 | US20060135434 New peptides |
| 06/22/2006 | US20060135431 Peptides and related molecules that bind to TALL-1 |
| 06/22/2006 | US20060135428 kringle peptides; peptidase stabilized |
| 06/22/2006 | US20060135426 Long lasting synthetic glucagon like peptide (GLP-1) |
| 06/22/2006 | US20060135418 Receptors |
| 06/22/2006 | US20060135416 Multifunctional context-activated protides and methods of use |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060135412 Methods for the treatment of alzheimers disease and compositions therefore |
| 06/22/2006 | US20060135408 Polypeptide biodrugs with given amino acid sequence which includes phosphorylated serine or threonine conjugated to a hydrophobic moiety such as a fatty acid; treating disorders such as Type II Diabetes, neurodegenerative diseases and psychological disorders |
| 06/22/2006 | US20060134801 Methods and compositions involving MDA-7 |
| 06/22/2006 | US20060134767 Mitotic kinesin binding site |
| 06/22/2006 | US20060134764 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 06/22/2006 | US20060134761 Expression vector coding a transcriptional activator protein for use animal feeds, human therapeutics and generation of preferential amino acids; fermentation |
| 06/22/2006 | US20060134760 Process for the production of L-amino acids using strains of the family enterobacteriaceae that contain an attenuated fruR gene |
| 06/22/2006 | US20060134756 Anti-IL-20 antibodies and binding partners and methods of using in inflammation |
| 06/22/2006 | US20060134755 IL-17 homologous polypeptides and therapeutic uses thereof |
| 06/22/2006 | US20060134754 IL-21 production in prokaryotic hosts |
| 06/22/2006 | US20060134753 consisting of a peptide fragment of SARS E2 spike protein, a peptide fragment of Pseudomonas exotoxin (PE) consisting of a binding domain and a translocation domain and a restriction enzyme site linker connecting the two; for inducing antibodies against SARS |
| 06/22/2006 | US20060134751 Identification of novel MS4A gene family members expressed by hematopoietic cells |
| 06/22/2006 | US20060134745 stress-related fusion proteins, antigenic peptides, and anti-stress-related antibodies; nucleic acid molecule encodes polypeptide which increases bile tolerance of cell; Lactobacillus acidophilus cell with an increased ability to survive stressful conditions compared to a wild-type |
| 06/22/2006 | US20060134744 Generating soluble human leukocyte antigens in cells from genomic DNA or cDNA, for prevention of viral, bacterial and proliferative disorders; polymerase chain reaction |
| 06/22/2006 | US20060134743 Vectors and methods for enhanced cell longevity and protein expression |
| 06/22/2006 | US20060134738 Gene expression inducing fusion protein and method for controlling gene expression Induction |
| 06/22/2006 | US20060134737 Ubiquitinated TNF receptor2 and its uses |
| 06/22/2006 | US20060134736 Human growth hormone conjugated with biocompatible polymer |
| 06/22/2006 | US20060134722 Method and compositions for detecting botulinum neurotoxin |
| 06/22/2006 | US20060134706 Atopic dermatitis inducer |
| 06/22/2006 | US20060134700 Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
| 06/22/2006 | US20060134699 Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
| 06/22/2006 | US20060134693 Olfactory cyclic nucleotide-gated channel cell-based assays to identify T1R and T2R taste modulators |
| 06/22/2006 | US20060134691 Labeling methodology comprising oligopeptides |
| 06/22/2006 | US20060134690 Process for the purification of interleukin-4 and its muteins |
| 06/22/2006 | US20060134682 Preparation and use of superior vaccines |
| 06/22/2006 | US20060134668 Methods for treating patients and identifying therapeutics |
| 06/22/2006 | US20060134655 Introducing a polynucleotide expressing a cGMP-visualizing probe into cells, whereby the cGMP-visualizing probe is expressed and made to coexist with cGMP; measuring the change in fluorescence wavelength |
| 06/22/2006 | US20060134634 Human gene |
| 06/22/2006 | US20060134610 Chris-like virus, compositions, vaccines and uses thereof |
| 06/22/2006 | US20060134604 Flexible method and apparatus for high throughput production and purification of multiple proteins |
| 06/22/2006 | US20060134143 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 06/22/2006 | US20060134138 Recombinant influenza viruses for vaccines and gene therapy |
| 06/22/2006 | US20060134135 Bacterial virulence genes |
| 06/22/2006 | US20060134133 An immunogenic composition containing modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes |
| 06/22/2006 | US20060134129 Anticancer agents; leukemia |
| 06/22/2006 | US20060134128 Screening for an inhibitor of binding between human Toll-like receptor 3 and a protein of specific amino acid sequence by contacting a candidate with a transfected cell encoding the protein which expresses the receptor; increased interferon in vivo; antitumor, autoimmune agents; side effect reduction |
| 06/22/2006 | US20060134127 Antiallergic agent |
| 06/22/2006 | US20060134126 Peptide constructs for treating disease |
| 06/22/2006 | US20060134124 Immunosuppression |
| 06/22/2006 | US20060134123 Comprise the gene of interest and a viral capsid or envelope carrying a member of a specific binding pair, the counterpart of which is not directly associated with the surface of the target cell; used in gene therapy |
| 06/22/2006 | US20060134117 Preventives/remedies for cancer |
| 06/22/2006 | US20060134116 Ca 125 tumor antigen function and uses thereof |
| 06/22/2006 | US20060134109 G protein coupled receptors and uses thereof |
| 06/22/2006 | US20060134103 Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligands |
| 06/22/2006 | US20060134094 Fibrin material and method for producing and using the same |
| 06/22/2006 | US20060134081 Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system |
| 06/22/2006 | US20060134065 Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 06/22/2006 | US20060134063 Agents for proliferating pancreatic beta-cells of the islets of langerhans, agents for suppressing apoptosis of said cells, and screening of candidate compounds for these agents |
| 06/22/2006 | US20060134061 Bisacyloxypropylcysteine conjugates and the use thereof |
| 06/22/2006 | DE102004060723A1 Biologically activated cell cultures, to develop a specific protein for therapeutic applications, uses a simultaneous incubation of somatic cells and biopsy material |
| 06/22/2006 | CA2836267A1 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 06/22/2006 | CA2594990A1 Biopolymer including prolamin and methods of making it |
| 06/22/2006 | CA2592344A1 Expression vectors for treating bacterial infections |
| 06/22/2006 | CA2591918A1 Cancer-specific spanx-n markers |
| 06/22/2006 | CA2591582A1 Methods and compositions for induction or promotion of immune tolerance |
| 06/22/2006 | CA2591421A1 Novel efficient production process for capsular polysaccharides of pathogenic grampositive bacteria by heterologous expression and secretion of complex polysaccharides in non-pathogenic, non-invasive gram- positive bacteria |
| 06/22/2006 | CA2591044A1 Adjuvant activity of gastrointestinal peptides |
| 06/22/2006 | CA2591035A1 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
| 06/22/2006 | CA2590851A1 Crystal structure of enzyme and uses thereof |
| 06/22/2006 | CA2590337A1 Humanized amyloid beta antibodies for use in improving cognition |
| 06/22/2006 | CA2589698A1 Improved dna immunization with recombinase/transposase |
| 06/22/2006 | CA2588594A1 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 06/22/2006 | CA2587285A1 Actinomadura chromoprotein, apoprotein, and gene cluster |
| 06/22/2006 | CA2587209A1 Osteoprotegerin variant proteins |
| 06/21/2006 | EP1672368A1 Diagnostic and therapeutic epitope and transgenic plant |
| 06/21/2006 | EP1672072A2 Cloning and characterisation of the gene flbA of H. pylori; production of flagella-free strains |
| 06/21/2006 | EP1672070A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/21/2006 | EP1672068A1 A method of affinity separation and ligands for use therein |
| 06/21/2006 | EP1672065A1 Protein expressed in nk cell |
| 06/21/2006 | EP1671981A2 Nucleic acids and proteins from streptococcus group A |
| 06/21/2006 | EP1671641A1 Remedy and therapeutic method for periodontal diseases and pulpal diseases |
| 06/21/2006 | EP1671535A1 Methods for altering levels of phenolic compounds in plant cells |
| 06/21/2006 | EP1671534A1 Methods for altering levels of phenolic compounds in plant cells |
| 06/21/2006 | EP1671131A1 Methods and kits for detection of prion diseases |
| 06/21/2006 | EP1671126A2 Diagnosis and treatment of mycobacterial infections |
| 06/21/2006 | EP1671097A2 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 06/21/2006 | EP1670928A2 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 06/21/2006 | EP1670926A2 Modified cea /b7 vector |
| 06/21/2006 | EP1670925A1 Packaging cells for recombinant adenovirus |
| 06/21/2006 | EP1670923A1 Method for mass production of human follicle stimulating hormone |
| 06/21/2006 | EP1670918A1 Leader sequences for use in production of proteins |
| 06/21/2006 | EP1670916A1 Banana resistance genes and uses thereof |
| 06/21/2006 | EP1670909A2 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
| 06/21/2006 | EP1670903A2 Treatment of neurodegenerative diseases |
| 06/21/2006 | EP1670899A2 Vaccines for cancer, autoimmune disease and infections |
| 06/21/2006 | EP1670894A2 Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
| 06/21/2006 | EP1670827A2 Anti-ghrelin antibodies |
| 06/21/2006 | EP1670824A2 Norovirus monoclonal antibodies and peptides |
| 06/21/2006 | EP1670823A1 Chimeric mhc protein and oligomer thereof for specific targeting |
| 06/21/2006 | EP1670822A2 Igf binding proteins |
| 06/21/2006 | EP1670821A1 Process for purifying human thrombopoietin with high content of sialic acid |
| 06/21/2006 | EP1670820A2 Antigens for an east coast fever vaccine |